Seer(SEER) - 2024 Q3 - Quarterly Results

Seer Reports Third Quarter 2024 Financial Results Growing enthusiasm for Proteograph Product Suite with multiple larger orders from government agencies and continued strong interest in STAC REDWOOD CITY, Calif. Nov 6, 2024 – Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today reported financial results for the third quarter ended September 30, 2024. Recent Highlights • Achieved revenue of $4.0 million for the third quarter of 2024 • Ente ...